InvestorsHub Logo
Followers 34
Posts 3000
Boards Moderated 0
Alias Born 02/27/2016

Re: None

Friday, 07/21/2023 10:46:05 PM

Friday, July 21, 2023 10:46:05 PM

Post# of 461946
How about some transparency and clear statements about where we are in our progress? That would be great and not very hard to do and would keep us from making up imaginary scenarios about where we are headed. Instead many here including myself are confused and frustrated.

How about something like this which is pretty simple and straightforward.

We released our Alz data and we know it is not "standard". We left out some numbers since the data needs context for you to fully appreciate it. We presented it in this way because we thought it was the best way to capture our success in the limited time we had.

We are diligently working on it and are including additional biomarkers so you can fully understand what we have and will be bringing to the FDA in hopes of an Accelerated Approval. This will take some time. The peer review paper is in progress and there are some things we need to save for that, however we will present everything else that we can.

The Rett data is coming out next month and we want to file the NDA for that before the Alz in order to secure the voucher. We want to use this money to expedite our newly planned trials and to find our commercialization plans. The Alz NDA will be filed shortly afterwards.

If he said something like this no one would have any questions and it would help us be a little more patient.

Yea. I like my hand to be held. I like straightforward talk. Unfortunately we don’t have this and likely won’t get it any time soon. So we just wait and wait some more. I am confident in our direction however unclear it is and will see it to completion.

And yes, I will be mad and complaining along the way with many of you here.

I think we may possibly almost Have This but am not sure. Ha!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News